1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Urine Analyzers - Medical Devices Pipeline Assessment, 2016

Urine Analyzers - Medical Devices Pipeline Assessment, 2016

Summary

GlobalData's Medical Devices sector report, “Urine Analyzers - Medical Devices Pipeline Assessment, 2016" provides an overview of Urine Analyzers currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Urine Analyzers pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Urine Analyzers under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Urine Analyzers and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Urine Analyzers under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table Of Contents

Urine Analyzers - Medical Devices Pipeline Assessment, 2016
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 3
1.2 List of Figures 3
2 Introduction 4
2.1 Urine Analyzers Overview 4
3 Products under Development 5
3.1 Urine Analyzers - Pipeline Products by Stage of Development 5
3.2 Urine Analyzers - Pipeline Products by Territory 6
3.3 Urine Analyzers - Pipeline Products by Regulatory Path 7
3.4 Urine Analyzers - Pipeline Products by Estimated Approval Date 8
3.5 Urine Analyzers - Ongoing Clinical Trials 9
4 Urine Analyzers - Pipeline Products under Development by Companies 10
4.1 Urine Analyzers Companies - Pipeline Products by Stage of Development 10
4.2 Urine Analyzers - Pipeline Products by Stage of Development 11
5 Urine Analyzers Companies and Product Overview 12
5.1 Analyticon Biotechnologies AG Company Overview 12
5.1.1 Analyticon Biotechnologies AG Pipeline Products and Ongoing Clinical Trials Overview 12
5.2 Biosense Technologies Pvt Ltd. Company Overview 14
5.2.1 Biosense Technologies Pvt Ltd. Pipeline Products and Ongoing Clinical Trials Overview 14
5.3 Erba Diagnostics, Inc. Company Overview 17
5.3.1 Erba Diagnostics, Inc. Pipeline Products and Ongoing Clinical Trials Overview 17
5.4 Roche Diagnostics International Ltd. Company Overview 19
5.4.1 Roche Diagnostics International Ltd. Pipeline Products and Ongoing Clinical Trials Overview 19
5.5 Siemens Healthcare GmbH Company Overview 21
5.5.1 Siemens Healthcare GmbH Pipeline Products and Ongoing Clinical Trials Overview 21
5.6 Sysmex Corporation Company Overview 22
5.6.1 Sysmex Corporation Pipeline Products and Ongoing Clinical Trials Overview 22
5.7 Teco Diagnostics Company Overview 24
5.7.1 Teco Diagnostics Pipeline Products and Ongoing Clinical Trials Overview 24
6 Urine Analyzers- Recent Developments 25
6.1 Oct 01, 2015: David Pacitti to Lead Siemens Healthcare North America Regional Organization 25
6.2 Sep 07, 2015: Transasia Bio-Medicals Plans to Raise Funds through IPO 25
7 Appendix 26
7.1 Methodology 26
7.2 About GlobalData 28
7.3 Contact Us 29
7.4 Disclaimer 29

1.1 List of Tables
Table 1: Urine Analyzers - Pipeline Products by Stage of Development 5
Table 2: Urine Analyzers - Pipeline Products by Territory 6
Table 3: Urine Analyzers - Pipeline Products by Regulatory Path 7
Table 4: Urine Analyzers - Pipeline Products by Estimated Approval Date 8
Table 5: Urine Analyzers - Ongoing Clinical Trials 9
Table 6: Urine Analyzers Companies - Pipeline Products by Stage of Development 10
Table 7: Urine Analyzers - Pipeline Products by Stage of Development 11
Table 8: Analyticon Biotechnologies AG Pipeline Products and Ongoing Clinical Trials Overview 12
Table 9: CombiScan XL - Product Status 13
Table 10: CombiScan XL - Product Description 13
Table 11: Biosense Technologies Pvt Ltd. Pipeline Products and Ongoing Clinical Trials Overview 14
Table 12: uChek Universal - Product Status 14
Table 13: uChek Universal - Product Description 14
Table 14: Biosense Technologies Pvt Ltd. - Ongoing Clinical Trials Overview 15
Table 15: uChek Universal - A Prospective Observational Pilot Study to Test the Feasibility of Smartphone Enabled uChek Urinalysis Device in Bangladesh 16
Table 16: Erba Diagnostics, Inc. Pipeline Products and Ongoing Clinical Trials Overview 17
Table 17: Laura XL - Product Status 18
Table 18: Laura XL - Product Description 18
Table 19: Roche Diagnostics International Ltd. Pipeline Products and Ongoing Clinical Trials Overview 19
Table 20: Cobas 6500 Analyzer - Product Status 20
Table 21: Cobas 6500 Analyzer - Product Description 20
Table 22: Siemens Healthcare GmbH Pipeline Products and Ongoing Clinical Trials Overview 21
Table 23: Clinitek Atlas Next - Product Status 21
Table 24: Clinitek Atlas Next - Product Description 21
Table 25: Sysmex Corporation Pipeline Products and Ongoing Clinical Trials Overview 22
Table 26: Sysmex UX-2000 Integrated Urinalysis Instrument - Product Status 23
Table 27: Sysmex UX-2000 Integrated Urinalysis Instrument - Product Description 23
Table 28: Teco Diagnostics Pipeline Products and Ongoing Clinical Trials Overview 24
Table 29: Next Generation Urine Analyzer - Product Status 24
Table 30: Next Generation Urine Analyzer - Product Description 24
Table 31: Glossary 27

1.2 List of Figures
Figure 1: Urine Analyzers - Pipeline Products by Stage of Development 5
Figure 2: Urine Analyzers - Pipeline Products by Territory 6
Figure 3: Urine Analyzers - Pipeline Products by Regulatory Path 7
Figure 4: Urine Analyzers - Pipeline Products by Estimated Approval Date 8
Figure 5: Urine Analyzers - Ongoing Clinical Trials 9

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.